Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT)

CUSIP: 19240Q201

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
155,716,944
Total 13F shares
121,834,182
Share change
-250,984
Total reported value
$1,316,352,629
Put/Call ratio
73%
Price per share
$10.80
Number of holders
160
Value change
+$470,587
Number of buys
82
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 19240Q201?
CUSIP 19240Q201 identifies COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT) as of Q3 2024

As of 30 Sep 2024, Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 121,834,182 shares. The largest 10 holders included Point72 Asset Management, L.P., Kynam Capital Management, LP, FMR LLC, BlackRock, Inc., COMMODORE CAPITAL LP, TCG Crossover Management, LLC, Fairmount Funds Management LLC, VANGUARD GROUP INC, VR Adviser, LLC, and Paradigm Biocapital Advisors LP. This page lists 160 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.